{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:51:40Z","timestamp":1791049900684,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T00:00:00Z","timestamp":1039564800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> We evaluated transplant\u2010related mortality (TRM), leukaemia relapse, leukaemia\u2010free survival (LFS) and overall survival (OS) in patients receiving busulphan and cyclophosphamide (BuCy) or cyclophosphamide and total body irradiation (CyTBI) prior to allogeneic bone marrow transplantation (BMT) for acute myelogenous leukaemia (AML) in first remission. Outcomes of 381 human leucocyte antigen (HLA)\u2010matched sibling transplants using BuCy were compared with 200 transplants using CyTBI performed between 1988 and 1996. The incidence of hepatic veno\u2010occlusive disease was higher with BuCy (13%) than with CyTBI (6%) (<jats:italic>P<\/jats:italic>\u2003= 0\u00b7009). Risks of acute and chronic GVHD were similar. In multivariate analysis, relapse risk was higher in the BuCy group [relative risk (RR)\u2003=\u20031\u00b772; 95% confidence interval (CI), 1\u00b705\u20132\u00b781; <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7031]. Eleven of 373 evaluable patients in the BuCy group had a central nervous system relapse in contrast to none of 194 evaluable patients in the CyTBI group (<jats:italic>P<\/jats:italic>\u2003= 0\u00b7016). There were no differences in TRM, LFS and OS. CyTBI conditioning may lower relapse risk but produces comparable TRM, LFS and OS to BuCy for HLA\u2010matched sibling transplantation in first remission AML.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03973.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:49:38Z","timestamp":1047365378000},"page":"1115-1124","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide\u2013total body irradiation versus busulphan\u2013cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission"],"prefix":"10.1111","volume":"119","author":[{"given":"Mark R.","family":"Litzow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleska S.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Bolwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Camitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Copelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Grant","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Trigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,12,11]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702351"},{"key":"e_1_2_13_4_1","first-page":"189","article-title":"Bone marrow transplantation as the treatment of choice for \u2018good risk\u2019 adult patients with acute leukemia","volume":"92","author":"Beutler E.","year":"1979","journal-title":"Transactions of the Association of American Physicians"},{"key":"e_1_2_13_5_1","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V79.10.2578.bloodjournal79102578","article-title":"Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan\u2013Cytoxan versus Cytoxan\u2013total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse","volume":"79","author":"Blaise D.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_13_6_1","first-page":"480a","article-title":"Ten year follow\u2010up of a national randomized trial comparing CYTBI vs BUSCY as conditioning regimen for patients administered HLA\u2010identical marrow grafts for CR1 AML","volume":"96","author":"Blaise D.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.8.2187.2187"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.6.2036.2036"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.340"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2263.bloodjournal8582263"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00335-I"},{"key":"e_1_2_13_12_1","first-page":"203","article-title":"Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission","volume":"16","author":"Gale R.P.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.7.2322"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701334"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558081"},{"key":"e_1_2_13_17_1","first-page":"367","volume-title":"Bone Marrow Transplantation in Practice","author":"Horowitz M.M.","year":"1992"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-2728-9"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700994"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058131"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.9.2723.2723"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1681.x"},{"key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","article-title":"Increased risk of chronic graft\u2010versus\u2010host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long\u2010term results of a randomized trial in allogeneic marrow recipients with leukemia","volume":"93","author":"Ringd\u00e9n O.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_13_24_1","first-page":"557a","article-title":"Solid cancers in survivors of allogeneic bone marrow transplantation (BMT)","volume":"96","author":"Rizzo J.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_13_25_1","first-page":"236","article-title":"Busulfan and cyclophosphamide for marrow transplantation","volume":"4","author":"Santos G.W.","year":"1989","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_26_1","first-page":"s13a","article-title":"Allogeneic bone marrow transplantation in chronic myeloid leukemia: what is the best conditioning regime?","volume":"12","author":"Schwerdtfeger R.","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_27_1","first-page":"31","article-title":"Graft rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics","volume":"16","author":"Slattery J.T.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V49.4.511.511"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909133011109"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.5.1382.1382"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03973.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03973.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03973.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:09:34Z","timestamp":1697440174000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03973.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03973.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03973.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"2002-12-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}